1. Introduction {#s0005}
===============

Infectious bovine keratoconjunctivitis (IBK), commonly known as 'pinkeye', is a highly contagious disease among bovine populations that can spread rapidly within a herd through direct contact, nasal or ocular discharges and via insect vectors when the integrity of the cornea is compromised ([@bb0065]; [@bb0090]). All cattle breeds are considered susceptible, although a lower incidence of IBK has been reported in Brahman cattle and cattle with more periocular pigmentation ([@bb0010]). IBK can produce ocular discharge, epiphora, mild conjunctivitis and corneal opacity, resulting in transitory blindness in most cases. However, IBK outbreaks may result in more severe clinical signs, including infection of the cornea that may lead to ulceration and perforation of the eye ([@bb0040]). Most animals recover from infection, however permanent corneal scarring and vision loss have been associated with IBK. Considerable economic impact has been attributed to IBK, particularly due to reduced weight gain in calves at weaning and high costs associated with antibiotic treatment ([@bb0040]). Calves with IBK usually weigh an average of 6.8--13.6 kg less than unaffected pasture mates at weaning ([@bb0045]). Lower performance in post-weaning cattle has been documented, including reduced average daily gain, 365th day weight, and final weight ([@bb0005]; [@bb0085]; [@bb0105]). Additionally, the drug cost for treatment, decreased market value due to corneal scarring, loss of value of show and breeding stock, and reduced milk production from dairy animals make this disease a significant economic and animal welfare consideration ([@bb0090]).

Over the last 50 years, numerous epidemiological observations and experimental challenge models have implicated *Moraxella bovis* as the major causal agent of IBK ([@bb0050]; [@bb0090]). A major virulence factor of *Moraxella bovis* is a secreted cytotoxin shown to reproduce IBK lesions in calves ([@bb0015]; [@bb0035]). *Moraxella bovoculi*, a newly described species has been isolated and characterized in association with IBK in the absence of *Moraxella bovis* ([@bb0080]). *Mycoplasma* spp. have also been frequently reported as causal agents of bovine IBK, with *Mycoplasma bovoculi* being most prevalent ([@bb0075]; [@bb0095]; [@bb0115]). One IBK outbreak was attributed to the synergistic action of *Mycoplasma bovoculi* and *Mycoplasma bovis*, following the possible predisposing effect of bovine respiratory disease ([@bb0070]). Several studies have also suggested that bovine herpesvirus-1 (BHV-1) can also cause bovine IBK ([@bb0100]). It was experimentally demonstrated that BHV-1 serves as a predisposing factor for IBK after conjunctival inoculation of pure BHV-1 cultures caused conjunctivitis and blepharitis. Inoculation of BHV-1 cultures did not cause keratitis that can be produced by inoculation with pure cultures of *Moraxella bovis* ([@bb0100]; [@bb0135]).

Considering that several pathogens, alone or in combination, may be associated with individual cases of IBK, it is necessary to develop a sensitive and specific detection method for the most common IBK associated agents. Although treatment is not pathogen dependent, pathogen identification is very important to guide the selection and application of appropriate vaccines including the possible need to pursue autogenous vaccine productions. Therefore, the objective of this study was to develop a multiplex real-time PCR (mqPCR) assay for the detection and differentiation of *Moraxella bovis*, *Moraxella bovoculi*, *Mycoplasma bovis*, *Mycoplasma bovoculi* and BHV-1 from cattle, and to evaluate the prevalence of these five pathogens during an outbreak of naturally occurring IBK in cattle.

2. Materials and methods {#s0010}
========================

2.1. Primers and probes {#s0015}
-----------------------

All available gene sequences of *Moraxella bovis*, *Moraxella bovoculi*, *Mycoplasma bovis*, *Mycoplasma bovoculi*, and Bovine herpesvirus 1 were downloaded from GenBank database (<https://www.ncbi.nlm.nih.gov/genbank/>), and aligned and analyzed to identify conserved regions that could serve as potential targets. Primers and probes ([Table 1](#t0005){ref-type="table"} ) were selected using the online PCR design tool, Primer3 (<http://bioinfo.ut.ee/primer3-0.4.0/>). An 18S rRNA gene conserved in the bovine genome ([@bb0020]) was used as an internal control to monitor nucleic acid extractions and potential PCR inhibitions. All primers and probes were checked for potential formation of secondary structures using AutoDimer 1.0 software ([@bb0125]). Primers and probes were synthesized by Integrated DNA Technologies (Coralville, IA, USA).Table 1Primers and probes information for real-time PCR target genes.Table 1PanelPrimers/probesSequence (5′- 3′)Amplicon size (bp)Accession numberPanel 1Mora bovis-FGGTGACGACCGCTTGTTT63EF436233.1Mora bovis-RATCATCGCCTTCATCTCCAGThis studyMora bovis-Pr5′- Texas Red- CGATCGTTGCCTTTACCACC -3′Mora bovo-FGGTGATATTTATCATGAAGTTGTGAAA88KP410780.1Mora bovo-RTYTCAATTCATAATCACGATACTCAAGThis studyMora bovo-Pr5′-VIC-CCAAGATACTGCGGTAGGTAAACG-3′18S-FGGAGTATGGTTGCAAAGCTGA100DQ222453.118S-RGGTGAGGTTTCCCGTGTTG([@bb0020])18S-Pr5′-Cy5-AAGGAATTGACGGAAGGGCA-BHQ2--3′Panel 2Myco bovis-FGCTGATGGCGGTATACAACA110KX772802.1Myco bovis-RGCTTTGGTTTTGTGAAACTCThis studyMyco bovis-Pr5′- MAX-CGCTTAAAACGCTTAATATAAACATCC-3′Myco bovo-FAGCTATGGCAGGGGACAAC66JQ390390Myco bovo-RCCACGTTCAATGTCTTTACGGThis studyMyco bovo-Pr5′-FAM- TGGTGTTCTACTCCGTGG-3′BHV-1-FTCGCGCACTGAGCAGAC86KR230748.1BHV-1-RCCGTCGGTTGTAGAAAGCAGThis studyBHV-1-Pr5′- Texas Red-CCCGGGCTGGTAAACCTG-3′[^1]

2.2. Construction of recombinant plasmids for use as positive amplification controls {#s0020}
------------------------------------------------------------------------------------

Fragments (300--500 bp) encompassing the qPCR target region of *Moraxella bovis*, *Moraxella bovoculi*, *Mycoplasma bovis*, *Mycoplasma bovoculi* and BHV-1 were amplified. The gene segment of *Mycoplasma bovoculi* was synthesized by Genewiz (South Plainfield, NJ, USA). Amplified PCR products were cloned into pCR2.1 plasmid using the TOPO TA Cloning kit (Thermo Fisher Scientific, Waltham, MA, USA), according to the manufacturer\'s protocol with minor modifications. The ligation reaction for each target was mixed gently and incubated for 5--15 min at room temperature. For each ligation reaction, 1 vial of Mix&Go cells (50 μL) was removed from -80 °C storage and thawed on ice. Four microliters of ligation reaction was added, then the tube was immediately placed on ice for 5 min. Two-hundred microliters of S.O.C. medium was added, then the tube was incubated at 37 °C with shaking (300 rpm) for 1 h. Two volumes of the transformation mixtures, 20 μL and 100 μL, were spread-plated onto pre-warmed ampicillin-containing Luria-Bertani (LB) plates. The plates were incubated at 37 °C for 14--16 h. For each construct, 2--6 white colonies were picked for confirmation by PCR then subsequent secondary confirmation using DNA sequencing.

2.3. Assay formulation and optimization {#s0025}
---------------------------------------

Two mqPCR reactions were used: *Moraxella bovis*, *Moraxella bovoculi*, and 18S rRNA internal control were multiplexed into subpanel 1 and *Mycoplasma bovis*, *Mycoplasma bovoculi* and bovine BHV-1 into subpanel 2. Each mqPCR reaction was performed in a 20 μL volume that contained 10 μL of 2× iQ Multiplex Powermix (Bio-Rad, Hercules, CA), 0.5 μL of each primer pair at 10 pM/μL, 0.5 μL of each probe at 10 pM/μL, 5 μL of DNA, and nuclease-free water to achieve a final reaction volume of 20 μL. Reactions were run on a CFX96 Touch Real-Time PCR Detection System (BioRad, Hercules CA) using the following assay running conditions: initial denaturation for 10 min at 95 °C followed by 45 cycles of denaturation for 15 s at 95 °C, and combined annealing and extension for 60 s at 60 °C. The 60 °C optimal annealing/extension temperature was determined through a temperature gradient analysis.

2.4. Analytical sensitivity {#s0030}
---------------------------

Standard curves were generated by testing cloned plasmids of each pathogen in single and multiplex reactions. Plasmid DNA used to generate standard curves was also quantified using a NanoDrop 2000 (Thermo Fisher Scientific Inc., USA) following the manufacturer\'s instructions. To mimic a clinical testing condition, each plasmid was serially diluted in a bovine DNA extracted from bovine tissue homogenates (\~Ct 20 by 18S rRNA PCR) to supply with naturally occurring 18S rRNA internal control template, and each dilution was tested in triplicate. Correlation coefficients and PCR amplification efficiencies were determined using the CFX Manager software (BioRad, Hercules CA, USA). The Ct values were plotted with log dilutions. The slope of the linear regression was used to determine PCR amplification efficiencies (E) using the following equation: E = 10^(−1/slope)^-1. Standard curves were also used to determine the limit of detection (LOD) for each target. To increase the accuracy of each LOD, 2-fold serial dilutions were prepared from the last 10-fold dilution that still generated a positive signal, then tested in triplicate by real-time PCR. Final LOD was defined as the lowest concentration of each plasmid DNA that yielded a positive signal in all three replications. The lowest detectable copy number for each assay was calculated using the following equation ([@bb0060]; [@bb0120]):

$\mathit{Plasmid\ copies}/{\mu L} = \frac{\left( {6.02 \times 10^{23}} \right) \times \left( {X\mspace{2mu}{ng}/{\mu L} \times 10^{- 9}} \right)}{\mathit{Plasmid\ length}\ \left( {bp} \right) \times 660}$

2.5. Assay specificity {#s0035}
----------------------

To evaluate the assay\'s specificity, PCR products of these field samples positive for the five IBK pathogens were sequenced and searched in GenBank database for comparative matches. Furthermore, the assay specificity was also analyzed by testing 55 non-target samples or cultures positive for non-pinkeye pathogens were also used for specificity analysis. These non-target samples or cultures include bovine respiratory syncytial virus (BRSV), bovine coronavirus (BCoV), *Mannheimia haemolytica*, *Pasteurella multocida*, *Histophilus somni*, *Bibersteinia trehalosi*, bovine viral diarrhea virus (BVDV), bovine coronavirus (BCoV), bovine rotavirus group A (RVA), *Acinetobacter indicus, Staphylococcus aureus, Pseudomonas aeruginosa, Listeria monocytogenes*, *Cryptosporidia* spp. and *Neospora caninum*. 11 different serotype of *Salmonella* culture samples including Anatum, Mbandaka, Montevideo, Kentucky, Newport, Orion va.15+ 34+, Muenster, Anatum var. 15+, 34+, Muenster var. 15+, 34+, Schwarzengrund, Senftenberg and Orion var. 15+, and 8 different serogroups of *Escherichia coli* culture samples including O26, O103, O104, O157, O121, O145, O45 and O111 serogroups. Assay\'s intra-assay specificity was evaluated with five pools of the target plasmids that were created with one of the five targets absent from each pool. Each pool was then tested by a singleplex qPCR using primers and probes corresponding to the absent target.

2.6. Assay sensitivity on diagnostic samples {#s0040}
--------------------------------------------

A total of 1,791 bovine ocular swab samples from cattle with clinical signs of IBK mainly collected in the state of Kansas were tested using this multiplex real-time PCR panel. Eight eye swabs from asymptomatic animals were also collected to serve as negative samples for validation. The swab samples were transferred into 1 mL of 1× PBS and briefly vortexed. DNA was extracted from the supernatant using Qiagen (Valencia, CA, USA) QIAamp Viral RNA Mini Kit. Selected clinical samples that were positive by multiplex real-time PCR were confirmed by DNA sequencing.

3. Results {#s0045}
==========

3.1. PCR amplification efficiencies and correlation coefficients of the standard curves {#s0050}
---------------------------------------------------------------------------------------

Analytical sensitivities of each individual assay were determined by standard curves using plasmids as templates. The results are shown in [Fig. 1](#f0005){ref-type="fig"} . The correlation coefficients (R^2^) for each of the five singleplex assays were all \>0.99, and PCR amplification efficiencies were between 90.8% and 105.3%. Standard curve results from each subpanel of the two multiplex real-time PCRs are shown in [Fig. 2](#f0010){ref-type="fig"} . Subpanel 1, that includes *Moraxella bovis*, *Moraxella bovuculi*, and the 18S rRNA internal control, had R^2^ \> 0.99 for both targets with PCR amplification efficiencies of 91.7% for *Moraxella bovis* and 96.2% for *Moraxella bovuculi*. Similarly, for the subpanel 2 multiplex real-time PCR that includes *Mycoplasma bovis Mycoplasma bovoculi*, and BHV-1, R^2^ values were all \>0.99 and PCR amplification efficiencies were 95.1%, 98.8% and 90.3% for the three pathogens, respectively ([Table 2](#t0010){ref-type="table"} ).Fig. 1Standard curves of singleplex real-time PCR reactions. The X-axis represents log concentration (copies of plasmids/reaction), and the Y-axis represents cycle threshold (Ct) values. Panel A represents: *Moraxella bovis*; B: *Moraxella bovuculi;* C: *Mycoplasma bovis*; D: *Mycoplasma bovoculi*; and E: BHV-1. Abbreviations: E: PCR amplification efficiency, R^2^: Correlation coefficient of the linear regression; Cq: quantification cycle, equivalent to Ct. y-int (Y-intercept) is the Cq value when X value is zero.Fig. 1Fig. 2Standard curves of multiplex real-time PCR reactions. The X-axis represents log concentration (copies of plasmids/reaction), and the Y-axis represents cycle threshold (Ct) values. Panel A: Standard curves of subpanel 1 including *Moraxella bovis* (Texas Red), *Moraxella bovuculi* (HEX), and 18S rRNA (CY5, a constant concentration was used). Panel B: Standard curves of subpanel 2 including *Mycoplasma bovoculi* (FAM), *Mycoplasma bovis* (HEX) and BHV-1 (Texas-Red). Abbreviations: E: PCR amplification efficiencies, R^2^: correlation coefficients; Cq: quantification cycle. y-int (Y-intercept) is the Cq value when X value is zero. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 2Table 2Analytical comparison of PCR amplification efficiencies, correlation coefficients and limit of detection between singleplex and multiplex reactions.Table 2TargetPCR reaction formatPCR amplification efficiency (%)Correlation coefficient (R^2^)Limit of detection (copy/reaction)*Moraxella bovis*singleplex105.90.99320multiplex101.10.99219*Moraxella bovoculi*singleplex99.40.99821multiplex92.80.99223*Mycoplasma bovis*singleplex98.10.99822multiplex99.10.99625*Mycoplasma bovoculi*singleplex99.20.99823multiplex96.60.99624Bovine herpes virus 1singleplex97.00.99926multiplex92.30.99826[^2]

3.2. The limit of detection of the PCR assay {#s0055}
--------------------------------------------

The copy number for each target was detected using a serial dilution of the plasmids. Results indicate that this assay has a high sensitivity in detecting these five pathogens. The average singleplex PCR detection limits for *Moraxella bovis*, *Moraxella bovoculi*, *Mycoplasma bovis*, *Mycoplasma bovoculi* and BHV-1 were 20, 21, 22, 23 and 26 copies per reaction, respectively ([Table 2](#t0010){ref-type="table"}). The average multiplex PCR detection limits for *Moraxella bovis*, *Moraxella bovoculi*, *Mycoplasma bovis*, *Mycoplasma bovoculi* and BHV-1 were 19, 23, 25, 24 and 26 copies per reaction, respectively, which are nearly identical to those generated by singleplex reactions.

3.3. Analytical specificity {#s0060}
---------------------------

PCR products of field samples (*n* = 179) positive for IBK pathogens were submitted for DNA sequencing. No non-specific positive signals were observed in the 179 clinical samples. The intra-assay specificity analysis of the five non-target plasmid pools did not result in any non-target cross amplification. The assay specificity was also analyzed by testing 55 non-target positive samples. Again, no non-specific positive signals were observed in the 55 non-IBK clinical samples.

3.4. Prevalence of the five pathogens in IBK samples {#s0065}
----------------------------------------------------

The percentage of positive samples for *Mycoplasma bovoculi*, *Moraxella bovoculi*, *Moraxella bovis*, BHV-1 and *Mycoplasma bovis* were: 88.8% (159/179), 75.9% (136/179), 60.3% (108/179), 11.7% (21/179) and 7.6% (9.5/179), respectively ([Fig. 3](#f0015){ref-type="fig"}A). Among the 179 positive clinical samples, 95 (53.0%) samples were positive for both *Moraxella bovis* and *Moraxella bovoculi*; 100 (55.8%) samples were positive for both *Moraxella bovis* and *Mycoplasma bovoculi*; 129 (72.0%) samples were positive for both *Moraxella bovoculi* and *Mycoplasma bovoculi* and 93 (51.9%) samples were positive for *Moraxella bovis*, *Moraxella bovoculi* and *Mycoplasma bovoculi* ([Fig. 3](#f0015){ref-type="fig"}B). Results suggest that *Moraxella bovis*, *Moraxella bovoculi* and *Mycoplasma bovoculi* have a higher prevalence than *Mycoplasma bovis* and BHV-1 in IBK samples collected from this study population.Fig. 3The prevalence of the five pathogens in IBK samples. Panel A: Prevalence of the five pathogens from the 179 bovine ocular swab samples that were subjected to multiplex real-time PCR testing. Panel B: Co-infections among the three most prevalent IBK pathogens in the 179 positive clinical samples: 95 (53.0%) samples were positive for both *Moraxella bovis* and *Moraxella bovoculi*; 100 (55.8%) samples were positive for both *Moraxella bovis* and *Mycoplasma bovoculi*; 129 (72.0%) samples were positive for both *Moraxella bovoculi* and *Mycoplasma bovoculi* and 93 (51.9%) samples were positive for *Moraxella bovis*, *Moraxella bovoculi* and *Mycoplasma bovoculi*.Fig. 3

4. Discussion {#s0070}
=============

A variety of pathogens have been associated with cases of IBK, however, causative agents most frequently include *Moraxella bovis*, *Moraxella bovoculi*, *Mycoplasma bovis*, *Mycoplasma bovoculi* and BHV-1. *Moraxella bovis* was long considered the sole causative agent of IBK, since it was most often isolated from clinical cases ([@bb0055]; [@bb0090]). Recently, another *Moraxella* species, *Moraxella bovoculi,* was isolated from calves with IBK ([@bb0015]). During a drug efficacy trial conducted in northern California, IBK-affected eyes of dairy and beef calves were cultured, and in most calves, hemolytic Gram-negative cocci but not *Moraxella bovis* were isolated. In a few cases, both *Moraxella bovis* and hemolytic Gram-negative cocci were isolated ([@bb0030]). The hemolytic Gram-negative cocci were subsequently characterized; biochemical and molecular data showed that these isolates were distinct from *Moraxella bovis* and *Moraxella ovis* and warranted their classification as a novel species named *Moraxella bovoculi* ([@bb0015]). The frequency of co-isolations may indicate that *Moraxella bovoculi* may be serving as an opportunistic agent or colonizing eyes in conjunction with *Moraxella bovis*, which has been shown to experimentally induce characteristic corneal ulcers in gnotobiotic calves ([@bb0110]). In this study, clinical sample data supports that *Moraxella bovis* and *Moraxella bovoculi* have a high prevalence, some are with very high concentrations, in these IBK samples ([@bb5000]).

*Mycoplasma* spp. is also highly prevalent in the conjunctivae of cattle with IBK, with *Mycoplasma bovoculi* being the most commonly identified species ([@bb0115]; [@bb0130]). Whether *Mycoplasma bovoculi* alone can cause clinical IBK, or act as a predisposing factor enhancing the effects of *Mycoplasma* spp. is currently unclear. Herds with a high prevalence of *Mycoplasma bovoculi* are more predisposed to acute IBK, possibly due to this pathogen facilitating enhanced infection with *Moraxella* spp. ([@bb0115]). An outbreak of IBK has even been attributed to the synergistic action of *Mycoplasma bovoculi* and *Mycoplasma bovis*, following the possible predisposing effects of bovine respiratory disease ([@bb0070]). However, doubts have also been raised over the infective potential of *Mycoplasma bovoculi* to cause IBK in the absence of pathogenic *Moraxella* spp. In the past, classical culture methods were used for epidemiological investigations of *Mycoplasma* spp. infections ([@bb0130]). However, the unique biochemical properties of *Mycoplasma* spp. have made it difficult to culture the bacteria ([@bb0025]), which may have impacted the prevalence data in these studies. PCR may circumvent some of these diagnostic challenges, since it offers a sensitive, rapid, robust and high-throughput application for detection. Our data suggests that *Mycoplasma bovoculi* has a higher prevalence than *Mycoplasma bovis* in IBK samples collected from this study population. Selected samples that were positive by the real-time PCR were sequence-confirmed to further support the PCR data.

Another significant infectious agent associated with IBK is BHV-1, which also causes respiratory tract disease in cattle. It was experimentally demonstrated that BHV-1 serves as a predisposing factor for IBK after conjunctival inoculation of pure BHV-1 cultures caused conjunctivitis and blepharitis. Inoculation of BHV-1 cultures did not cause keratitis which can be produced by inoculation with pure cultures of *Moraxella bovis* ([@bb0100]; [@bb0135]). High concentrations of BHV-1 have been shown to shed primarily by respiration and ocular secretions from infected animals, making it easily transmittable among animals ([@bb0135]). However, the virus can also be transmitted indirectly through people and equipment ([@bb0100]). Our data show that animals with clinical IBK lesions had a low prevalence (10.0%) of BHV-1 infection.

In conclusion, we have developed a multiplex real-time PCR panel assay for the detection and differentiation of *Moraxella bovis*, *Moraxella bovoculi*, *Mycoplasma bovis*, *Mycoplasma bovoculi* and BHV-1 from cattle. Results from this study suggest that *Moraxella bovis*, *Moraxella bovoculi* and *Mycoplasma bovoculi* have a higher prevalence than *Mycoplasma bovis* and BHV-1 in bovine IBK samples collected from the state of Kansas. This assay may serve as a viable alternative or supplemental detection method for traditional culture methods.
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[^1]: Note: F: Forward primer; R: Reverse primer; Pr: Probe; FAM: Fluorescein, or Fluorescein amidite; Texas Red: sulforhodamine 101 acid chloride; MAX: Rhodamine (HEX or VIC equivalent); VIC: 2′-chloro-7\'phenyl-1,4-dichloro-6-carboxy-fluorescein; Cy5: Cyanine 5; BHQ: Black-Hole Quencher. All sequence accessions listed in the table are submitted by other researchers. They are listed as a representative accession from which the primers and probes were designed.

[^2]: Note: PCR amplification efficiency (E) is calculated by E = 10^(−1/slope)^−1.
